HIV-1 phenotyping provides antiretroviral susceptibility information for protease inhibitors (PI) and reverse transcriptase inhibitors (NRTI, NNRTI). Intended for patients with viral load >500 copies/mL.
Drug Susceptibility using HIV Culture
Lavender (EDTA) or plasma preparation tube (PPT).
Separate plasma from cells within 6 hours of collection. Transfer 3 mL plasma to an ARUP Standard Transport Tube and freeze immediately. (Min: 3 mL)
CRITICAL FROZEN. Separate specimens must be submitted when multiple tests are ordered.
Provide patient's most recent viral load and viral load collection date. Procedure should be used for patients with documented HIV-1 infection and viral loads greater than 500 copies/mL.
Ambient: Unacceptable; Refrigerated: Unacceptable; Frozen: 2 weeks
No compliance statements are in use for this test.
87903; 87904 x11
|Component Test Code*||Component Chart Name||LOINC|
|0092074||Viral Load Date||19151-0|
|2003231||EER HIV Phenotype Comprehensive||11526-1|
- HIV-1 Resistance